RESUMEN
BACKGROUND: Platelet-rich plasma (PRP) and botulinum toxin type A (BTX-A) injections have proven effective in clinical trials for plantar fasciitis treatment but have not been directly compared. We aimed to compare clinical outcomes in patients undergoing PRP or BTX-A injections. METHODS: We performed a randomised controlled trial (59 patients; 1-year follow-up) to assess efficacy, using pain and functional scales (VAS, AOFAS Hindfoot-scale and FAAM questionnaire) and fascia thickness reduction, in control and single ultrasound-guided BTX-A or PRP injection groups. RESULTS: The BTX-A group showed better results at 1-month after treatment. Conversely, the PRP injection was more effective in the long-term, with significant pain reduction and functional improvement. Plantar fascia thickness significantly reduced from months 1 and 3 in the PRP and BTX-A groups, respectively. CONCLUSION: PRP and BTX-A injections are effective in patients with plantar fasciitis with BTX-A achieving better short-term pain reduction and PRP better long-term results. LEVEL OF EVIDENCE: Level I; Randomised Controlled Trial.
Asunto(s)
Toxinas Botulínicas Tipo A , Fascitis Plantar , Plasma Rico en Plaquetas , Humanos , Fascitis Plantar/terapia , Fascitis Plantar/tratamiento farmacológico , Toxinas Botulínicas Tipo A/uso terapéutico , Dolor , Ultrasonografía Intervencional , Resultado del TratamientoRESUMEN
INTRODUCTION: Synovial osteochondromatosis is a rare condition characterized by the formation of multiple cartilaginous nodules, which involves metaplastic changes of the synovium and is commonly found in larger joints. Occurrence in foot and ankle is uncommon, even less in metatarsophalangeal joints. CASE REPORT: A 54-year-old woman with primary synovial osteochondromatosis in the first metatarsophalangeal joint was treated by complete excision plus synovectomy. After 8years of follow-up, the patient remains symptom free with no recurrence observed. A summary of the case and review of all published cases found in the current literature around this location is discussed. CONCLUSION: Though rare, synovial chondromatosis should be considered as a differential diagnosis in a refractory synovitis and tumor mass in the metatarsophalangeal joint of the hallux.
